Apolipoprotein (apo) B, the critical structural protein of the atherogenic lipoproteins, has two
major isoforms: apoB48 and apoB100. ApoB48 is found in chylomicrons and chylomicron …

Numerous epidemiological and clinical studies demonstrate the beneficial effects of
naturally occurring, polyphenol supplementations, on cardiovascular system. The present …

The authors review the association between diabetes mellitus (DM) and aberrations of lipid
metabolism related to DM, diabetic dyslipidemia (DD). DM is considered as a major health …

Sodium glucose co-transporter 2 (SGLT2) inhibitors are effective antihyperglycemic agents
by inhibiting glucose reabsorption in the proximal tubule of the kidney. Besides improving …

Atherosclerosis is a life-long illness that begins with risk factors, which in turn contribute to
the development of subclinical disease, followed by the establishment of overt …

Metabolic syndrome (MetS) is a leading public health and clinical challenge worldwide.
MetS represents a group of interrelated risk factors that predict cardiovascular diseases …

Atherosclerosis is responsible for large cardiovascular mortality in many countries globally. It
has been shown over the last decades that the reduction of atherosclerotic progression is a …

The obesity pandemic is accompanied by increased risk of developing metabolic syndrome
(MetS) and related conditions: non-alcoholic fatty liver disease (NAFLD)/non-alcoholic …

Based on available data, adiponectin represents a multifaceted biomarker that may
beneficially affect atherosclerosis, inflammation and insulin resistance pathways. However …

Cardiovascular diseases (CVDs) are one of the major causes of mortality and disability in
Western countries. Prevention is known to be the cornerstone to lessen the incidence of …